Life Sciences Academy by Osborne Clarke

US biosecurity policy is rapidly evolving. The proposed Biosecure Act and related regulations are poised to reshape how biotech and pharma companies source, partner, and invest across borders. This webinar breaks down what’s changing, who is affected, and what EU/UK companies with US touchpoints should be doing now. We cover:

• Expected timelines, scope, and obligations under the Biosecure Act
• How other related regulations impact supply chains, research collaborations (including university/CRO arrangements), and capital flows
• Practical steps to prepare—counterparty screening, contractual protections, JV/transaction structuring, and governance
• Q&A session to help you translate policy awareness into concrete action.

Webinar recorded 12th February 2026

This practical webinar sets out a cross-border playbook for post-deal integration in life sciences, focusing on immediate post‑completion priorities and the early integration phase. Our panel of corporate, tax and regulatory specialists highlights common pitfalls and UK/EU nuances, sharing clear, actionable steps to maintain momentum and protect deal value.

Webinar recorded 23rd October 2025

Are you ready to navigate the complexities of the new European Health Data Space (EHDS) regulation? Join our webinar for an exclusive one-hour presentation where our experts explore the implications of this ground breaking new regulation that has a major impact on health and life sciences companies. Our team of experts guide you through the key aspects of the EHDS, offering practical insights and answering pressing questions for businesses.

Webinar recorded 17th June 2025

Gain valuable insights and practical knowledge on the latest legislative changes in the EU pharmaceutical sector, including regulatory updates, data exclusivity, and supplementary protection certificates. This webinar equips attendees with the tools to adapt to the new regulatory environment and optimise their IP strategies.

With multiple biotech and pharma hubs and world class research institutions, the United States is by some distance the world leader in life sciences R&D. For a large number of our clients, the US is also a core market for their products. Keeping abreast of regulatory and practical developments around doing business in the US is essential to maintaining commercial success.

Join us for an insightful webinar where our experts interview Michael P. Strazella, Senior Principal, Co-Head of Government Relations and Health Industry at Buchanan. Michael shares his expertise on the latest policy developments under the new Trump Administration and their implications for the life sciences and healthcare sectors.

Webinar recorded 30th April 2025

This webinar delves into the intricacies of commercial terms in pharma and biotech license agreements to maximise benefits. Our experts provide valuable tips on structuring these agreements to maximise benefits, with a focus on perspectives from both the UK and Germany. Key topics include royalty stacking, combination products, sublicense fees, and the net sales definition. Enhance your understanding and unlock the full potential of your licensing deals.

Webinar recorded 11 March 2025.

From AI Protection to AI Innovation through case studies in the Pharma & MedTech Industries

We delve into the fascinating world of AI in pharma and medtech, exploring among other things, how AI tools and AI-developed results are protectable under relevant IP laws, and whether AI may be legally recognised as an ‘inventor’ or ‘creator’ from an IP law perspective. We also examine challenges surrounding the protection of training data and trade secrets and provide insights on contract compliance and contractual protection strategies.

Webinar recorded 10th December 2024

Our life sciences patent litigators build on their experience with the UPC and introduce the audience to the latest and most relevant case law for life sciences companies. We present practical steps to help businesses prepare to successfully enforce and defend their rights before the UPC.

Webinar recorded 19 November 2024

We approach this webinar from the structure of a typical acquisition process of target companies active in the Life Sciences sector. We discuss regulatory and IP items that we often encounter in Europe and explain how they can impact the overall acquisition process and timing.

Webinar recorded 29th October 2024

An exclusive webinar which dives deep into the intricate world of foreign direct investment (FDI) regulation, unravelling the complexities of FDI controls and their significant influence on M&A transactions and investments within the life sciences and healthcare sector.

Webinar recorded 10th September 2024